Evaluation of gatifloxacin penetration into skeletal muscle and lung by microdialysis in rats

International Journal of Pharmaceutics

Volumn 358, Issue 1-2, 2008, Pages 96-101

  Tasso, Leandro ^a   Bettoni, Clarissa C ^a   Oliveira, Laura K ^b   Costa, Teresa Dalla ^a,b  

^a Programa de Pos Graduacao em Biologia Animal   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Gatifloxacin; Lung penetration; Microdialysis; Skeletal muscle penetration; Wistar rats

Indexed keywords

GATIFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG SCREENING; IN VITRO STUDY; IN VIVO STUDY; LUNG FLUID; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; ANTI-BACTERIAL AGENTS; FLUOROQUINOLONES; LUNG; MALE; MICRODIALYSIS; MUSCLE, SKELETAL; PROTEIN BINDING; RATS; RATS, WISTAR; SOLVENTS;

EID: 44449129855     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.02.023     Document Type: Article

References (38)

1. Allegranzi B., Cazzadori A., Di Perri G., et al. Concentrations of single-dose meropenem (1 g i.v.) in bronchoalveolar lavage and epithelial lining fluid. J. Antimicrob. Chemother. 46 (2000) 319-322
2. Bellmann R., et al. Tissue pharmacokinetics of levofloxacin in human soft tissue infections. Br. J. Clin. Pharmacol. 57 (2004) 563-568
3. Bellmann R., Kuchling G., Dehghanyar P., Zeitlinger M., Minar E., Mayer B.X., Müller M., and Joukhadar C. Tissue pharmacokinetics of levofloxacin in human soft tissue infections. Br. J. Clin. Pharmacol. 57 (2004) 563-568
4. Bergogne-Bérézin E. Clinical role of protein binding of quinolones. Clin. Pharmacokinet. 41 (2002) 741-750
5. Brunner M., Hollesnstein U., Delacher S., Jager D., Schmid R., Lackner E., Georgopoulos A., Eichler H.G., and Müller M. Distribution and antimicrobial activity of ciprofloxacin in human soft tissues. Antimicrob. Agents Chemother. 43 (1999) 1307-1309
6. Brunner M., Pernersdorfer T., Mayer B., Eichler H.G., and Müller M. Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit. Care Med. 28 (2000) 1754-1759
7. Brunner M., and Langer O. Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution. AAPS 8 (2006) E263-E271
8. Chaurasia, C.S., et al., 2007. AAPS-FDA workshop white paper microdialysis principles, application, and regulatory perspectives report from the joint AAPS-FDA workshop, November 4-5, 2005, Nashville, TN. AAPS. 9, E48-E59.
9. Derendorf H. Pharmacokinetic evaluation of beta-lactam antibiotics. J. Antimicrob. Chemother. 24 (1989) 407-413
10. Elmiquist W.F., and Sawchuk R.J. Application of microdialysis in pharmacokinetic studies. Pharm. Res. 14 (1997) 267-288
11. File Jr. T.M. Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia. Clin. Microbiol. Infect. 12 (2006) 31-41
12. Freddo R.J., and Dalla Costa T. Determination of norfloxacin free interstitial levels in skeletal muscle by microdialysis. J. Pharm. Sci. 91 (2002) 2433-2440
13. Herkner H., Müller M.R., Kreischitz N., Mayer B.X., Frossard M., Joukhadar C., Klein N., Lackner E., and Müller M. Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. Am. J. Crit. Care Med. 165 (2002) 273-276
14. Hutschala D., Skhirtladze K., Zuckermann A., Wisser W., Jaksch P., Mayer-Helm B.X., Burgmann H., Wolner E., Müller M., and Tschernko E.M. In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery. Antimicrob. Agents Chemother. 49 (2005) 5107-5111
15. Hyatt J.M., McKinnon P.S., Zimmer G.S., and Schentag J.J. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Clin. Pharmacokinet. 28 (1995) 143-160
16. Islinger F., et al. Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose. Antimicrob. Agents Chemother. 48 (2004) 4246-4249
17. Joukhadar C., Derendorf H., and Müller M. Microdialysis, a novel tool for clinical studies of anti-infective agents. Eur. J. Clin. Pharmacol. 57 (2001) 211-219
18. Kaplan V., Angus D.C., Griffin M.F., Clermont G., Scott W.R., and Linde-Zwirble W.T. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am. J. Respir. Crit. Care Med. 165 (2002) 766-772
19. Knaub S.R., Chang M.F., Lunte C.E., Topp E.M., and Riley C.M. Automated analytical systems for drug development studies. Part IV. A microdialysis system to study the partitioning of lomefloxacin across an erythrocyte membrane in vitro. J. Pharm. Biomed. Anal. 14 (1995) 121-129
20. Liu H.H. Use of the respiratory fluoroquinolones for the outpatient management of community-acquired pneumonia. Curr. Ther. Res. 65 (2004) 225-238
21. Marchand S., Dahyot C., Lamarche I., Mimoz O., and Couet W. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats. Antimicrob. Agents Chemother. 49 (2005) 2356-2361
22. Marrie T.J. Management decisions regarding community-acquired pneumonia. Clin. Infect. Dis. 12 (1999) 133-136
23. Minino A.M., and Smith B.L. Deaths: preliminary data for 2000. Nat. Vital Stat. Rep. 49 (2001) 1-40
24. Müller M., Brunner M., Hollenstein U., et al. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob. Agents Chemother. 43 (1999) 2056-2058
25. Müller M., Haag O., Burgdorff T., Georgopoulos A., Weninger W., Stanck G., Pehamberger H., Agneter E., and Eichler H.G. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob. Agents Chemother. 40 (1996) 2703-2709
26. Müller M., Schmid R., Georgopoulos A., Buxbaum A., Wasicek C., and Eichler H. Application of microdialysis to clinical pharmacokinetics in humans. Clin. Pharmacol. Ther. 57 (1995) 371-380
27. Müller M., Stass H., Brunner M., Moller J.G., Lackner E., and Eichler H.G. Penetration of moxifloxacin into peripheral compartments in humans. Antimicrob. Agents Chemother. 43 (1999) 2345-2349
28. Müller M., De la Peña A., and Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrob. Agents Chemother. 45 (2004) 1441-1453
29. Nolting A., Dalla Costa T., Vistelle R., Rand K.H., and Derendorf H. Determination of free extracellular concentrations of piperacillin by microdialysis. J. Pharm. Sci. 85 (1996) 369-372
30. Plock N., and Kloft C. Microdialysis-theoretical background and recent implementation in applied life-sciences. Eur. J. Pharm. Sci. 25 (2005) 1-24
31. Rodvold K.A., and Neuhauser M. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Pharmacotherapy 21 (2001) 233S-252S
32. Rosón B., Carratalá J., Dorca J., Casanova A., Manresa F., and Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin. Infect. Dis. 33 (2001) 158-165
33. Sasongko L., Williams K.M., Brune K., and McLacklan A.J. Assessment of in vitro and in vivo recovery of gallamine using microdialysis. J. Pharmacol. Toxicol. Methods 44 (2000) 519-525
34. Tasso L., and Dalla Costa T. High performance liquid chromatography for quantification of gatifloxacin in rat plasma following automated on-line solid phase extraction. J. Pharm. Biomed. Anal. 44 (2007) 205-210
35. Tegeder I., Schmidtko A., Bräutigam L., Kirschbaum A., Geisslinger G., and Lötsch J. Tissue distribution of imipenem in critically ill patients. Clin. Pharmacol. Ther. 71 (2002) 325-333
36. Tomaselli F., Dittrich P., Maier A., Woltsche M., Matzi V., Pinter V., Nubsbaumer S., Pinter H., Smolle J., and Smolle-Jüttner F.M. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis. Br. J. Clin. Pharmacol. 55 (2003) 620-624
37. Tomaselli F., Maier A., Matzi V., Smolle-Jüttner F.M., and Dittrich P. Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis. Antimicrob. Agents Chemother. 48 (2004) 2228-2232
38. Zeitlinger M.A., Dehghanyar P., Mayer B.X., Chenk B.S., Neckel U., Heinz G., Georgopoulos A., Müller M., and Joukhadar C. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob. Agents Chemother. 47 (2003) 3548-3553